Paolo Aretini

Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)

Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 668 citations · Full text

Medicine, Genetics, Oncology +15

Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer

Timothy R. Rebbeck, Nandita Mitra, Fei Wan et al. · JAMA · 2015 · 509 citations · Full text

Medicine, Genetics, Oncology +17

Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study

Cristian Scatena, Manuela Roncella, Antonello Di Paolo et al. · Frontiers in Oncology · 2018 · 132 citations · Full text

Medicine, Oncology, Pharmacology +17

KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma

Francesca Zammarchi, Mariangela Morelli, Michele Menicagli et al. · American Journal Of Pathology · 2011 · 86 citations · Full text

Medicine, Molecular Genetics, Oncology +11

Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development

Patrizia Sarogni, Orazio Palumbo, Adele Servadio et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 86 citations · Full text

Life Sciences, Genetics, Oncology +17